Publication | Closed Access

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Hematological MalignancyOncologyRelapsed Multiple MyelomaMedicineMalignant Blood DisorderHematologyPharmacotherapyPharmacologyCovariate Analysis